Danaher Corp. EO-Notes 2020(20/30)

BID
-
ASK
-
0 Nom.0 Nom.
07/27, 22:00:04 PM

SPREAD (ACT/ REL)- / -
CHANGE COMPARED WITH PREVIOUS DAY (PRICE)0.17%
TODAY'S HIGH (PRICE)97.1
TODAY'S LOW (PRICE)96.907
Week 52 High (Price)99.62
Week 52 Low (Price)96.25

Yield Curves

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

3.36

Yield spread Bundesanleihe

0.5249

Tradable for private investors

Minimum amount tradeable unit

100,000.00

Maturity

30/03/2030

Interest Rate

2.50 %

Currency

Euro

Facts & figures

Price data


TRADE PLATFORM	Börse Stuttgart (XSTU)
LAST PRICE / YIELD	97.076 G / 3.36	0 Units
PRICE DETERMINATION TIME	07/27/2026 / 09:48:02 PM
DAILY VOLUME (NOMINAL)	0
YIELD SPREAD	0.5249
FIXINGPRICE	-
DAILY HIGH / LOW	97.1	96.907
PREV. DAY'S PRICE	96.914	(07/24)
CHANGE DAY BEFORE	+0.16	0.17 %
52 WEEK HIGH / LOW	99.617 (10/28)	96.253 (03/23)

More Price Information

Master Data


WKN	A28VFP
ISIN	XS2147995372
SYMBOL	-
EXCHANGE SEGMENT	Freiverkehr
TYPE OF FINANCIAL INSTRUMENT	Corporate Bond
SUB-TYPE	Health Care
ISSUER	Danaher Corp.
S&P RATING	Please log in to view this field
(TRADING) SEGMENT / TICKS	-/ -
TRADING HOURS	07:30:00 AM - 10:00:00 PM
INTEREST RATE	2.50 %
INTEREST RUN FROM	30/03/2020
NEXT INTEREST PAYMENT	16/03/2027
UNIT INTEREST FROM NOMINAL AMMOUNT	0.925 %


TRADING CURRENCY / NOTATION	Euro/ Percent
NOMINAL CURRENCY	Euro
SETTLEMENT CURRENCY	Euro
QUOTATION	Continuous trading
ISSUING VOLUME	800.00 Mil.
MINIMUM AMOUNT TRADEABLE UNIT	100,000.00
SMALLEST TRADEABLE UNIT	1,000.00
MATURITY	30/03/2030
MARKET MAKER	-
STEP UP/ DOWN WHEN RATING CHANGES	No
STEP UP FIXED AT ISSUE	No
STEP DOWN FIXED AT ISSUE	No
BOND CALLABLE BY THE ISSUER	Yes
BOND IS SUBORDINATED	No

Description

Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.